Logo image of 1BA.MI

BOEING CO/THE (1BA.MI) Stock Fundamental Analysis

BIT:1BA - Euronext Milan - US0970231058 - Common Stock - Currency: EUR

165.6  -12.78 (-7.16%)

Fundamental Rating

1

Taking everything into account, 1BA scores 1 out of 10 in our fundamental rating. 1BA was compared to 41 industry peers in the Aerospace & Defense industry. 1BA may be in some trouble as it scores bad on both profitability and health. 1BA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year 1BA has reported negative net income.
1BA had a negative operating cash flow in the past year.
1BA had negative earnings in each of the past 5 years.
In multiple years 1BA reported negative operating cash flow during the last 5 years.
1BA.MI Yearly Net Income VS EBIT VS OCF VS FCF1BA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

1BA's Return On Assets of -7.59% is on the low side compared to the rest of the industry. 1BA is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1BA.MI Yearly ROA, ROE, ROIC1BA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

1BA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1BA.MI Yearly Profit, Operating, Gross Margins1BA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

1BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
1BA has more shares outstanding than it did 1 year ago.
1BA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1BA has an improved debt to assets ratio.
1BA.MI Yearly Shares Outstanding1BA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1BA.MI Yearly Total Debt VS Total Assets1BA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

1BA has an Altman-Z score of 1.09. This is a bad value and indicates that 1BA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.09, 1BA is doing worse than 80.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACC8.69%
1BA.MI Yearly LT Debt VS Equity VS FCF1BA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

1BA has a Current Ratio of 1.32. This is a normal value and indicates that 1BA is financially healthy and should not expect problems in meeting its short term obligations.
1BA has a better Current ratio (1.32) than 72.22% of its industry peers.
A Quick Ratio of 0.42 indicates that 1BA may have some problems paying its short term obligations.
1BA's Quick ratio of 0.42 is on the low side compared to the rest of the industry. 1BA is outperformed by 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.42
1BA.MI Yearly Current Assets VS Current Liabilites1BA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

3

3. Growth

3.1 Past

1BA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -250.00%.
1BA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.50%.
The Revenue has been decreasing by -4.74% on average over the past years.
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%

3.2 Future

1BA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.11% yearly.
Based on estimates for the next years, 1BA will show a quite strong growth in Revenue. The Revenue will grow by 15.55% on average per year.
EPS Next Y92.35%
EPS Next 2Y48.3%
EPS Next 3Y33.32%
EPS Next 5Y20.11%
Revenue Next Year24.77%
Revenue Next 2Y20.43%
Revenue Next 3Y17.37%
Revenue Next 5Y15.55%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1BA.MI Yearly Revenue VS Estimates1BA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
1BA.MI Yearly EPS VS Estimates1BA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

1BA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year 1BA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1BA.MI Price Earnings VS Forward Price Earnings1BA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1BA.MI Per share data1BA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as 1BA's earnings are expected to grow with 33.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.3%
EPS Next 3Y33.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1BA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

BIT:1BA (3/3/2025, 7:00:00 PM)

165.6

-12.78 (-7.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners75.41%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap124.21B
Analysts76.67
Price Target182.72 (10.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.94
Dividend Growth(5Y)-11.02%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.7%
Min EPS beat(2)-91.07%
Max EPS beat(2)3.66%
EPS beat(4)2
Avg EPS beat(4)-23.11%
Min EPS beat(4)-91.07%
Max EPS beat(4)37.77%
EPS beat(8)4
Avg EPS beat(8)-7.22%
EPS beat(12)4
Avg EPS beat(12)-872.64%
EPS beat(16)5
Avg EPS beat(16)-763.86%
Revenue beat(2)0
Avg Revenue beat(2)-5.74%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1.93%
Revenue beat(12)2
Avg Revenue beat(12)-4.68%
Revenue beat(16)2
Avg Revenue beat(16)-5.02%
PT rev (1m)0.36%
PT rev (3m)3.71%
EPS NQ rev (1m)-164.41%
EPS NQ rev (3m)-203.03%
EPS NY rev (1m)-818.48%
EPS NY rev (3m)-401.29%
Revenue NQ rev (1m)-0.79%
Revenue NQ rev (3m)-12.75%
Revenue NY rev (1m)-0.86%
Revenue NY rev (3m)-2.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.96
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-19.44
EYN/A
EPS(NY)-1.49
Fwd EYN/A
FCF(TTM)-18.32
FCFYN/A
OCF(TTM)-15.37
OCFYN/A
SpS84.64
BVpS-4.97
TBVpS-17.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 126.25%
Cap/Sales 3.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.42
Altman-Z 1.09
F-Score2
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
EPS Next Y92.35%
EPS Next 2Y48.3%
EPS Next 3Y33.32%
EPS Next 5Y20.11%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%
Revenue Next Year24.77%
Revenue Next 2Y20.43%
Revenue Next 3Y17.37%
Revenue Next 5Y15.55%
EBIT growth 1Y-1218.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.06%
EBIT Next 3Y50.8%
EBIT Next 5Y32.37%
FCF growth 1Y-424.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-302.68%
OCF growth 3YN/A
OCF growth 5YN/A